Benzodiazepine Addiction and Management
| Registration |
|---|
The estimated time to complete this course is 60 minutes. Learners will complete a post-assessment with a minimum score of 75%. Before enrolling in this educational activity, you must log in or create an account. Once you register for the course, you will have 30 days from the date of enrollment to complete the course. The date your access expires will be indicated in the Course Summary box on this webpage. |
Target Audience
Healthcare professionals.
Educational Need
Benzodiazepines are commonly prescribed for the treatment of anxiety disorders, insomnia, seizure disorders, and other clinical conditions; however, prolonged use can lead to physiologic dependence, problematic use, and withdrawal-related complications. Healthcare professionals frequently encounter patients taking benzodiazepines long-term but may have limited training in distinguishing appropriate therapeutic use from benzodiazepine use disorder, assessing dependence severity, identifying withdrawal risks, and implementing evidence-based tapering strategies.
This activity addresses the need for clinicians to improve their recognition and assessment of benzodiazepine use disorder and to understand factors that increase the risk of dependence, misuse, and withdrawal complications. Participants will gain practical knowledge and skills to evaluate benzodiazepine use, identify patients who may benefit from dose reduction, and develop individualized tapering plans that prioritize patient safety, minimize withdrawal symptoms, and support successful long-term outcomes.
Learning Objectives
- Recognize the clinical features of benzodiazepine use disorder.
- Distinguish problematic use from appropriate therapeutic use.
- Assess the severity of benzodiazepine dependence.
- Identify patient risk for withdrawal complications.
- Develop a benzodiazepine tapering plan based on patient-specific factors, while minimizing withdrawal symptoms and promoting safety.
Speakers

Michelle Davids, DO
Psychiatrist, Broadlawns Medical Center

Omar Rodriguez, MD
Broadlawns UnityPoint Psychiatry Residency Program
Terms of Use and Privacy Policy
Recording date: October 16, 2026
Date of original release: October 16, 2026
Most recent review/update: October 16, 2026
Termination date: October 15, 2029
Course summary
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA 1-B
- 1.00 CE Contact Hour(s)
- 1.00 Nursing Contact Hour(s)
Accreditation Statements
- DO: Des Moines University Medicine and Health Sciences (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 1.0 AOA Category 1-B credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
- MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS). Des Moines University Medicine and Health Sciences (DMU) is accredited by the IMS to provide continuing medical education for physicians. DMU designates this enduring materials activity for 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Nurses: Des Moines University Medicine and Health Sciences has determined that this activity meets the requirements for 1.0 contact hours as defined by the Iowa Board of Nursing and Iowa Administrative Code 481-619.
- Other healthcare providers: This activity is designated for 1.0 AMA PRA Category 1 Credit(s)™.
![]() | ![]() |
Educational Grants
No ineligible company provided financial support for this continuing education activity.
Disclosures
The speaker(s) will disclose if any pharmaceuticals, medical procedures, or devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The activity director is responsible for determining educational content and selecting speakers.
Relevant to the content of this educational activity, the following individual(s) have no conflict(s) with ineligible companies to disclose.
- Michelle Davids, DO - Speaker
- Omar Rodriguez, MD - Speaker
Disclaimer
The information provided in this activity is for continuing education purposes only. It is not a substitute for a healthcare provider's independent medical judgment regarding diagnostic and treatment options for a specific patient's medical condition.
Available Credit
- 1.00 AMA PRA Category 1 Credits™
- 1.00 AOA 1-B
- 1.00 CE Contact Hour(s)
- 1.00 Nursing Contact Hour(s)

Facebook
X
LinkedIn
Forward
